As shown in Figure 6(a), the PI3K/AKT/mTOR pathway was enriched with high PYCR2 expression phenotype (P < 0.05), indicating that the PI3K/AKT/mTOR pathway could be involved in the cancer-promoting effect of activated PYCR2. Here, MTOR is linked to cancer.